Studies show integrated program effective for depression in patients with cancer.
Risk is greater in patients managed with watchful waiting than in those who undergo radical treatment.
In a study, none of the 62 men who had the treatment experienced erectile dysfunction or urinary incontinence.
Diffusion-weighted technique found to have a sensitivity and specificity of 89%-91% and 77%-81%, respectively.
At 5 years after seed implantation, 59% prostate cancer patients had preserved erectile function.
In a study, the 12-year prostate cancer survival rate was 61.8% for men with the mutation versus 94.3% for those without it.
Urinary levels of a melatonin metabolite below the median were associated with a 4-fold increased risk versus levels above the median.
Increased absolute effect at 13 years compared with findings at nine and 11 years.
It is more sensitive than digital rectal examination and transrectal ultrasound and more specific than PSA and PSA density, researchers report.
A questionnaire-based study revealed significant side effects that are not commonly discussed.
Reduced likelihood of biochemical recurrence of prostate cancer also linked to concomitant hormonal therapy and positive surgical margins.
As body mass index increases, so does the risk of kidney and bladder cancers in men and stomach, ovarian, and colon cancers in women.
Epigenetic assay has a high negative predictive value for prostate cancer.
Study reveals a 2-fold greater likelihood of primary kidney and bladder cancer compared with men in the general population.
Patients with substance use disorder are more likely to be hospitalized and to make emergency department visits.
Experts note study findings aren't definitive, and risk is minimal.
Study finds a 19% increased risk of distant metastases or death from the cancer.
Those with depression, intermediate- or high-risk disease undergo less treatment.
Men who took cranberry capsules during and after external beam radiation treatment experienced less severe symptoms of cystitis.
Use of low-molecular-weight heparin decreased the risk of death by 52%.
In a study, the biochemical recurrence-free and metastasis-free survival rates were 73% and 97.5%, respectively, at 10 years.
Prostate cancer patients with health insurance are less likely to present with metastatic disease or die from the cancer than uninsured patients.
After 5 years, nearly two thirds of men remained on active surveillance.
Men aged 61 and older at diagnosis are more likely to die from the malignancy than men aged 50 or younger.
Transient rises in PSA after radiotherapy may be due to late damage to healthy prostatic tissue, evidence suggests.
Increased long-term risk observed in men on active surveillance.
Most physicians report that their patients are not interested in active surveillance.
Compared with whites, blacks and Hispanics have 42% and 23% increased odds, respectively, of being diagnosed with high-risk prostate cancer.
Other predictors include the presence of more than 1 positive biopsy core and a greater tumor burden.
This rate of incidental PCa detection is lower than found in previous studies.